Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. [electronic resource]
Producer: 20100301Description: 342-50 p. digitalISSN:- 1532-1827
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms
- CDC2 Protein Kinase -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase 2 -- metabolism
- Estrogen Receptor Modulators -- pharmacology
- Female
- Humans
- Protein Kinase Inhibitors -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.